Rocket Pharmaceuticals Inc. (RCKT)
NASDAQ · Healthcare
Rocket Pharmaceuticals Inc. Shareholder Equity 2016–2025
Rocket Pharmaceuticals Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Rocket Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 277.2M, a 40.16% decrease year-over-year.
- Rocket Pharmaceuticals Inc. shareholder equity for 2025 were 277.2M, a 40.16% decrease from 2024.
- Rocket Pharmaceuticals Inc. shareholder equity for 2024 were 463.2M, a 5.96% decrease from 2023.
- Rocket Pharmaceuticals Inc. shareholder equity for 2023 were 492.6M, a 0.59% increase from 2022.
- Rocket Pharmaceuticals Inc. shareholder equity for 2022 were 489.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Rocket Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $277 |
| 2024 | $463 |
| 2023 | $493 |
| 2022 | $490 |
| 2021 | $455 |
| 2020 | $504 |
| 2019 | $307 |
| 2018 | $194 |
| 2017 | $16 |
| 2016 | $8 |
Rocket Pharmaceuticals Inc. Shareholder Equity — FAQ
Rocket Pharmaceuticals Inc. (RCKT) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RCKT's shareholder equity history?
The chart and table above show Rocket Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.